FDA clears use of Novo’s obesity drug to protect heart health

FDA clears use of Novo’s obesity drug to protect heart health

Submitted by admin on March 10, 2024 - 8:43pm
Source: 
BioPharma Dive
News Tags: 
Novo Nordisk
FDA
Wegovy
Headline: 
FDA clears use of Novo’s obesity drug to protect heart health
snippet: 

The Food and Drug Administration has expanded the label for Novo Nordisk’s fast-selling weight loss drug Wegovy following study results that proved the medicine can protect heart health. 

Do Not Allow Advertisers to Use My Personal information